During the 12th Five-Year Plan period, the country included the "nutrition and health food manufacturing industry" in the national development plan for the first time. By the 14th Five-Year Plan period, China advocated the development of traditional Chinese medicine health products. After entering into 21st century, our country's population aging is intensifying gradually, and middle and elderly people are the biggest consumption crowd of health care products. Along with our country's elderly population continues to increase, the consumption market of health care products will also continue to expand.
The market scale of health care products continues to rise, and the health care products enterprises are concentrated in the east area
Driven by many positive factors such as policy encouragement, aging population and residents' income growth, China's health products market continues to develop and the market size continues to rise. With the continuous growth of the market demand for health products, the market scale of health products will continue to climb. Health care products enterprises are concentrated in the eastern part of China, and Guangdong Province has the largest number of health care products enterprises in the first half of 2022. Secondly, the number of health care products enterprises in Shandong Province is second only to Guangdong Province.
Three, enterprise analysis: health care products enterprise operating revenue stable growth, gross margin maintained at a high level
Tomson Bihealth is the leading enterprise in the health care product industry in China. In 2021, the market share of Tomson BiHealth in the health care product industry is 9.3%. The main business of Tomson BiHealth is health care products. The business income of health care products accounts for more than 99% of the total business income of Tomson BiHealth. Its gross profit rate is always maintained at a high level, stable at more than 60%. At present, the tablet and capsule products account for the largest proportion of the existing production capacity of Tomson BiHealth, which is also a relatively common form of health products in the market.
Iv. Development trend: The market demand for health care products continues to grow, and the industry speeds up its development to high quality
The improvement of economic conditions makes people pay more attention to health, and consumers are more willing to pay for "health". Moreover, along with the in-depth understanding and understanding of the health care products, more and more consumers can understand and treat the health care products function correctly, the health care products consumption gradually trend daily, our health care products market will attract a large growth. At the same time, with the increasing consumer demand for health care products and the continuous refinement of demand fields, health care products production and suppliers will be promoted to refine research fields, expand R&D investment, and enhance product competitiveness.
Key words: health care products aging Tomson Bihealth
I. Development environment: Policies encourage the development of health care products, and the aging population accelerates the growth of market demand for health care products
Health care products refer to products that regulate body functions, are not intended for therapeutic purposes, and do not cause any acute, subacute or chronic harm to the human body. Health care products are a kind of food, with the common characteristics of general food, it contains a certain amount of effective ingredients, can regulate the function of the human body, has a specific effect, suitable for specific people. For example, lipid-lowering health care products are mainly targeted at patients with high lipids; Vitamin health products for the lack of all kinds of vitamin population; Enhance immunity type health care products are targeted at people with weak constitution and low resistance. However, health care products can not be directly used for disease treatment, only as a mechanism regulator or nutritional supplement. The upstream of health care products is dominated by raw materials, including biopharmaceuticals, Chinese medicinal materials and chemicals, etc. The midstream is the production and supplier of health care products, such as Tomson Bihealth, Wuji, Health Yuan and other well-known enterprises, while the downstream is delivered to consumers through drug stores, supermarkets, e-commerce platforms and other sales channels.
The development of the health care product industry in our country began in 1980s. After the reform and opening up, the residents' income level and the consumption level rise accordingly, making the market demand of health care products rise sharply. In the early stage, the vigorous development of the health care product industry also brought some hidden dangers, such as the production and sale of fake and inferior products. Therefore, the state gradually carried out strict regulations and supervision on the health care product industry. At the same time, in order to meet the growing market demand of the health care product industry, the state also introduced policies to guide and encourage the development of the health care product industry. During the 12th Five-Year Plan period, the state included "nutrition and health food manufacturing industry" in the national development plan for the first time. During the 13th Five-Year Plan period, the state continued to release policies to encourage the development of health food, and to the 14th Five-Year Plan period, China advocated to vigorously develop traditional Chinese medicine health products. In January 2022, the State Administration of Traditional Chinese Medicine issued the Development Plan for Promoting High-quality Integration of Traditional Chinese Medicine into the Belt and Road Initiative to encourage the development of health care products in the Belt and Road Initiative.
The per capita disposable income of Chinese residents increased year by year from 2015 to 2021. In 2021, the per capita disposable income of Chinese residents was 35,128 yuan, an increase of 9.1%. In the first three quarters of 2022, the per capita disposable income of Chinese residents was 27,650 yuan, an increase of 1,385 yuan compared to the same period last year. The increase of national income also further enhances the purchasing power of Chinese residents, and people's living standards continue to improve. They pay more attention to personal nutrition and health status in addition to meeting food and clothing. Therefore, from 2015 to 2021, China's per capita healthcare expenditure also shows a rising trend on the whole, and the per capita healthcare expenditure in 2021 is 2,115 yuan. With a year-on-year increase of 14.76 percent, China's per capita health care spending in the first three quarters of 2022 was 1,596 yuan, up 39 yuan from the same period last year. The steady growth of economy has become an important driving force in the health product industry. In the future, under the steady development of our economy, the health product will usher in the stable market growth.
Health care products have certain efficacy, which makes them more widely used in middle-aged and old people and young people. Among them, the penetration rate of 55-64 years old is 29%, followed by that of 45-54 years old and 65 years old and above 20%. In the middle and next years, health products are mainly aimed at the daily health care of various diseases of the elderly, while in the adolescents, it is mainly vitamin supplement health products.
After entering the 21st century, the aging of the Chinese population has gradually intensified. From 2015 to 2021, the number of people over the age of 65 will continue to rise, and the growth rate will also increase on the whole. In 2021, the number of people over the age of 65 will grow by 6.8% to 203.6 million. The MIDDLE and ELDERLY PEOPLE ARE THE HEALTH PRODUCTS THE BIGGEST ConSUMPTION CROWD, AS THE OLD PEOPLE IN OUR COUNTRY ConTINUES TO INCREASE, THE ConSUMPTION MARKET OF THE HEALTH PRODUCTS WILL ALSO ConTINUE TO ENLARGE.
Related Report: Report on Market Panorama Survey and Strategic Consulting of China's Health Products Industry (2023-2029) released by Zhiyan Consulting
The market scale of health care products continues to rise, and the health care products enterprises are concentrated in the east area
Driven by policy encouragement, the aging of the social population and the growth of residents' income, China's health care products market continues to develop and its market scale continues to rise. In 2021, the market scale of health care products has increased to 270.8 billion yuan, an increase of 8.19% compared with the previous year. With the continuous growth of the market demand for health products, the market scale of health products will continue to climb.
Since health food has certain efficacy, the state strictly supervises its production. The production of health food must be approved by the State Food and Drug Administration. In 2021, more than half of the registered domestic health food products were immune-enhancing products. Health care products to relieve physical fatigue were the next most popular, accounting for 16 percent.
Health care products enterprises are concentrated in the eastern part of the country. Guangdong Province has the largest number of health care products enterprises in the first half of 2022, with 1,875 health care product producers and suppliers. Guangdong Province is located in the southeast coastal area, the economy is relatively developed, consumers have stronger consumption power of health care products, health care products enterprises in Guangdong Province include Tomson Bihealth, No Limit, Baiyunshan, etc. In addition, Shandong Province is second only to Guangdong Province in the number of health care products enterprises, with 1,313, including Dong 'e Ejiao, Baihe Shares, Xiwang Food, etc.
Three, enterprise analysis: health care products enterprise operating revenue stable growth, gross margin maintained at a high level
Due to the low entry threshold of the health care product industry, coupled with the continuous increase of policies to encourage the health care product industry in recent years and the continuous growth of market demand, a large number of enterprises have been attracted to enter the industry. The market of the health care product industry is relatively scattered and the concentration is not high. Tomson Bihealth is the leading enterprise in the health care product industry in China. In 2021, the market share of Tomson BiHealth in the health care product industry is 9.3%. Driven by the continuous demand for health care products in China, the operating revenue of Tomson BiHealth increased to 7.431 billion yuan in 2021, a year-on-year growth of 22%. In the first three quarters of 2022, the operating revenue of Tomson BiHealth was 6.16 billion yuan, an increase of 2.18% compared with the same period last year, which continued to grow.
The main business of Tomson BiHealth is health care products, and the business income of health care products accounts for more than 99% of its total business income. From 2017 to 2021, the business revenue of health care products of Tomson BiHealth increased steadily year by year, increasing to 7.375 billion yuan in 2021, with a year-on-year growth of 21.4%, accounting for 99.25% of the total business revenue of the enterprise. From 2017 to 2021, the gross profit margin of Tomson BiHealth health products has always maintained at a high level, stable at more than 60%.
In the face of the rapidly growing market demand, health care products production and supply enterprises on the one hand increase the investment in research and development, enhance the competitive strength of their own products, on the other hand, actively expand production capacity, enhance the product supply capacity of enterprises, seize market shares. In 2021, Tomson BiHealth is building production lines for tablets, powder strips, liquid beverages and drops health products. At present, the tablet and capsule products account for the largest proportion of the existing production capacity of Tomson BiHealth, which is also a relatively common form of health products in the market.
Iv. Development trend: The market demand for health care products continues to grow, and the industry speeds up its development to high quality
1. The consumption of health care products has gradually become routine, and the market demand for health care products has increased significantly
With the rapid development of our economy and society, the market demand for health care products also grows fast. The improvement of economic conditions makes people pay more attention to health, and consumers are more willing to pay for "health". At the same time, with the change of economic level and living environment, people's health awareness is enhanced, and the functional demand for health care products is also increased, which is no longer simply to enhance immunity or supplement vitamins. With the vigorous development of health economy, people's demand for health care products in various subareas such as "weight management", "appearance management" and "sports nutrition" is also growing rapidly. For example, the demand for whitening health products, metabolic promotion products, nutritional meal replacement products and so on are growing rapidly. In addition, with people's in-depth understanding and understanding of health care products, more and more consumers can correctly understand and treat the efficacy of health care products, and the consumption of health care products gradually tends to be routine. On the other hand, due to the enhancement of people's health awareness, people's demand for nutrition and health is gradually increasing, but the contemporary young people's fast pace of life, the pursuit of high efficiency, so compared with the traditional diet, they prefer and convenient and fast and good taste of health products. Therefore, under the economic development, consumer consumption habits change and other positive factors, Chinese health products market will attract considerable growth.
2, consumers to improve the quality of health care products, promote the industry to improve quality and upgrade
The health care product is the fast developing industry under the background of the rapid development of Chinese economy and society. Therefore, in the future, with the high quality development of Chinese economy, the health care product industry will also develop to the high quality. In particular, with the enhancement of consumers' health awareness and correct understanding of health care products, the market has improved the quality requirements of health care products. At the same time, the market of Chinese health products industry is relatively dispersed, with low concentration and numerous practitioners in the industry. In order to occupy a strong position in the fierce market competition, it is necessary to strengthen the development of new products and the improvement of product quality. At present, the innovation degree of health product market remains to be improved, and the homogenization of products in the market is relatively high. With the increasing demand of consumers for health care products and the continuous refinement of demand fields, health care products production and suppliers will be promoted to refine research fields, expand research and development investment, and enhance product competitiveness.
The above data and information can be referred to the "2023-2029 China Health products Industry Market Panorama Survey and Strategic Consulting Research Report" released by Zhiyan Consulting. Zhiyan Consulting is a comprehensive information and intelligence provider in the field of industrial consulting in China. The company takes "using information to drive industrial development and empower enterprise investment decision-making" as its brand concept. To provide professional industrial consulting services for enterprises, the main services include fine industry research reports, special customization, monthly special topics, research reports, business plans, industrial planning, etc. Provide regular reports and customized data such as weekly/monthly/quarterly/annual report, covering policy monitoring, enterprise dynamics, industry data, product price changes, investment and financing overview, market opportunities and risk analysis, etc.